Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Athar Mahmood Qureshi, MD, is a Staff member in Pediatric Cardiology at Cleveland Clinic Children’s Hospital Center for Pediatric and Congenital Heart Disease in Cleveland, Ohio. A Pediatric Cardiologist, Dr. Qureshi joined the Children’s Hospital in 2005. He also holds the positions of Assistant Professor of Pediatrics at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Quality Improvement Officer of The Center for Pediatric and Congenital Heart Disease at The Cleveland Clinic, and Pediatric Institute Physician Liaison for Sheikh Khalifa Medical City in Abu Dhabi.
Previously, he was a Senior Fellow in Interventional Cardiology at the Children’s Hospital Boston/Harvard Medical School, Boston, Mass. He is certified by the American Board of Pediatrics and American Board of Pediatric Cardiology. His specialty interests include diagnostic and interventional cardiac catheterization in pediatric patients and congenital heart disease.
Dr. Qureshi received his medical degree from Aga Khan University Medical College in Karachi, Pakistan. He completed a residency and internship at SUNY Health Sciences Center in Syracuse, N.Y., where he also received an award for excellence in teaching. He completed his fellowship in pediatric cardiology at Cleveland Clinic and received the Chairman’s Award for Research Excellence by a Fellow.
Dr. Qureshi is Principal Investigator or Co-Investigator in several ongoing research studies. His articles have been published in leading peer-reviewed journals, and he has authored chapters for books in his areas of expertise. He is a team member of International Children's Heart Foundation, a US-based organization that provides care for patients with congenital heart disease in underprivileged areas of the world.
In his leisure time, Dr. Qureshi enjoys his time with his family, traveling, hiking and playing cricket.
Interventional and diagnostic catheterization in children and adults with congenital heart disease
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/6/2013, Dr. Qureshi has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.